SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Bacterial Infections - Pipeline Review, H2 2012 Report Features Players such as Bausch & Lomb Incorporated and Ancora Pharmaceuticals Inc.

[January 14, 2013]

Research and Markets: Bacterial Infections - Pipeline Review, H2 2012 Report Features Players such as Bausch & Lomb Incorporated and Ancora Pharmaceuticals Inc.

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/6n47fn/bacterial) has announced the addition of Global Markets Direct's new report "Bacterial Infections - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial Infections. Bacterial Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direc's team.


Scope

- A snapshot of the global therapeutic scenario for Bacterial Infections.

- A review of the Bacterial Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Bacterial Infections pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Some of the Companies Mentioned:

Shionogi & Co., Ltd.

AlphaRx, Inc.

Sanofi-Aventis

AstraZeneca PLC

GlaxoSmithKline plc

Genentech, Inc.

Daiichi Sankyo Company, Ltd

Merck & Co., Inc.

Taisho Pharmaceutical Co., Ltd.

Dr. Reddy's Laboratories Limited

Meiji Holdings Co., Ltd.

Nippon Shinyaku Co., Ltd.

Pfizer Inc.

ConjuGon, Inc.

Aquapharm Biodiscovery Limited

Amura Holdings Ltd.

Aridis Pharmaceuticals LLC

AiCuris GmbH & Co. KG

Destiny Pharma Ltd.

AlphaVax, Inc.

NanoBio Corporation

iBio, Inc.

KYORIN Pharmaceutical Co., Ltd.

Trius Therapeutics, Inc.

SelectX Pharmaceuticals, Inc.

Spider Biotech S.r.l.

PepTx, Inc.

Durata Therapeutics Inc.

Cantab Biopharmaceuticals Limited

AlgiPharma AS

For more information visit http://www.researchandmarkets.com/research/6n47fn/bacterial

Source (News - Alert): Global Markets Direct


[ Back To education 's Homepage ]








Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy